In a mice model of ACL tears, anti-GDF8 administration attenuated posttraumatic OA occurrence and periarticular bone loss while genetic deletion prevented bone and muscle deficiency after ACL transection in mice, suggesting that blocking myostatin can function as a modality to prevent posttraumatic OA [157]. Here, MSTN is linked to hyperinsulinemic hypoglycemia, familial, 4.